Pular para o conteúdo principal

E. coli bacteria's defense secret revealed

In the periplasm -- the space between the inner and outer membranes of a bacteria's cell wall -- defensive proteins that detect a poison assemble like barrel staves to form a tunnel between pumps in the cell's inner and outer membranes to eject the intruders. Artist's conception by Ace George Santiago.
Credit: Ace George Santiago, Cornell University
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.

When undesirable molecules show up, the bacterial cell opens a tunnel though its cell wall and "effluxes," or pumps out, the intruders.

"Dynamic assembly of these tunnels has long been hypothesized," said Peng Chen, professor of chemistry and chemical biology. "Now we see them."

The findings could lead to ways to combat antibiotic-resistant bacteria with a "cocktail" of drugs, he suggests: "One is to inhibit the assembly of the tunnel, the next is to kill the bacteria."

To study bacteria's defensive process, Chen and colleagues at Cornell selected a strain of E. coli known to pump out copper atoms that would otherwise poison the bacteria. The researchers genetically engineered it, adding to the DNA that codes for a defensive protein an additional DNA sequence that codes for a fluorescent molecule.

Under a powerful microscope, they exposed a bacterial cell to an environment containing copper atoms and periodically zapped the cell with an infrared laser to induce fluorescence. Following the blinking lights, they had a "movie" showing where the tagged protein traveled in the cell. They further genetically engineered the various proteins to turn their metal-binding capability on and off, and observed the effects.

Their research was reported in the Early Online edition of the Proceedings of the National Academy of Sciences the week of June 12. The Cornell researchers also collaborated with scientists at the University of Houston, the University of Arizona and the University of California, Los Angeles.

The key protein, known as CusB, resides in the periplasm, the space between the inner and outer membranes that make up the bacteria's cell wall. When CusB binds to an intruder -- in this experiment, a copper atom -- that has passed through the porous outer membrane, it changes its shape so that it will attach itself between two related proteins in the inner and outer membranes to form a complex known as CusCBA that acts as a tunnel through the cell wall. The inner protein has a mechanism to grab the intruder and push it through.

The tunnel locks the inner and outer membranes together, making the periplasm less flexible and interfering with its normal functions. The ability to assemble the tunnel only when needed, rather than having it permanently in place, gives the cell an advantage, the researchers point out.

This mechanism for defending against toxic metals may also explain how bacteria develop resistance to antibiotics, by mutating their defensive proteins to recognize them. Similar mechanisms may be found in other species of bacteria, the researchers suggested.

Source: https://www.sciencedaily.com/releases/2017/06/170613145146.htm

Postado por David Araripe

Comentários

Postagens mais visitadas deste blog

CONSERVAÇÃO DE ALIMENTOS E A EQUAÇÃO DE ARRHENIUS por Carlos Bravo Diaz, Universidade de Vigo, Espanha

Traduzido por Natanael F. França Rocha, Florianópolis, Brasil  A conservação de alimentos sempre foi uma das principais preocupações do ser humano. Conhecemos, já há bastante tempo, formas de armazenar cereais e também a utilização de azeite para evitar o contato do alimento com o oxigênio do ar e minimizar sua oxidação. Neste blog, podemos encontrar diversos ensaios sobre os métodos tradicionais de conservação de alimentos. Com o passar do tempo, os alimentos sofrem alterações que resultam em variações em diferentes parâmetros que vão definir sua "qualidade". Por exemplo, podem sofrer reações químicas (oxidação lipídica, Maillard, etc.) e bioquímicas (escurecimento enzimático, lipólise, etc.), microbianas (que podem ser úteis, por exemplo a fermentação, ou indesejáveis caso haja crescimento de agentes patogênicos) e por alterações físicas (coalescência, agregação, etc.). Vamos observar agora a tabela abaixo sobre a conservação de alimentos. Por que usamo...

Two new proteins connected to plant development discovered by scientists

The discovery in the model plant Arabidopsis of two new proteins, RICE1 and RICE2, could lead to better ways to regulate plant structure and the ability to resist crop stresses such as drought, and ultimately to improve agricultural productivity, according to researchers at Texas A&M AgriLife Research. Credit: Graphic courtesy of Dr. Xiuren Zhang, Texas A&M AgriLife Research The discovery of two new proteins could lead to better ways to regulate plant structure and the ability to resist crop stresses such as drought, thus improving agriculture productivity, according to researchers at Texas A&M AgriLife Research. The two proteins, named RICE1 and RICE2, are described in the May issue of the journal eLife, based on the work of Dr. Xiuren Zhang, AgriLife Research biochemist in College Station. Zhang explained that DNA contains all the information needed to build a body, and molecules of RNA take that how-to information to the sites in the cell where they can be used...

Fármaco brasileiro aprovado nos Estados Unidos

  Em fotomicrografia, um macho de Schistosoma mansoni, causador da esquistossomose CDC/G. Healy A agência que regula a produção de alimentos e medicamentos dos Estados Unidos, a FDA, concedeu o status de orphan drug para o fármaco imunomodulador P-Mapa, desenvolvido pela rede de pesquisa Farmabrasilis, para uso no tratamento de esquistossomose.  A concessão desse status é uma forma de o governo norte-americano incentivar o desenvolvimento de medicamentos para doenças com mercado restrito, com uma prevalência de até 200 mil pessoas nos Estados Unidos, embora em outros países possa ser maior. Globalmente, a esquistossomose é uma das principais doenças negligenciadas, que atinge cerca de 200 milhões de pessoas no mundo e cerca de 7 milhões no Brasil.  Entre outros benefícios, o status de orphan drug confere facilidades para a realização de ensaios clínicos, após os quais, se bem-sucedidos, o fármaco poderá ser registrado e distribuído nos Estados Unidos, no Brasil e em outro...